Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩32,800, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 23% over the past three years. Annuncio • Jul 02
Soulbrain Holdings Co., Ltd. announced that it has received KRW 45 billion in funding from J& Alpha Ltd. On June 30, 2026, Soulbrain Holdings Co., Ltd. closed the transaction. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩37,750, the stock trades at a trailing P/E ratio of 11.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 38% over the past three years. Annuncio • Jun 16
Soulbrain Holdings Co., Ltd. announced that it expects to receive KRW 45 billion in funding from J& Alpha Ltd. Soulbrain Holdings Co., Ltd. announced a private placement of Series 3 Unregistered, non-interested, unsecured private convertible bonds of the company to raise gross proceeds of KRW 45,000,000,000 on June 15, 2026. The transaction involves participation from new investor J& Alpha Ltd. The Bonds are 100% convertible into 923,948 Common Shares of the company at a conversion price of KRW 48,704 and the conversion period will start from July 1, 2027 till May 31, 2031. The Bonds have zero coupon rate and zero maturity interest rate and will mature on June 30, 2031. The transaction has been approved by Board of Directors of the company. The transaction is expected to close on June 30, 2026. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩40,800, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 37% over the past three years. New Risk • May 30
New major risk - Revenue and earnings growth Earnings have declined by 1.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.5% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • May 12
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩61,000, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 115% over the past three years. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩71,000, the stock trades at a trailing P/E ratio of 33.1x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 173% over the past three years. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩54,900, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 80% over the past three years. New Risk • Mar 27
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 268% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. New Risk • Mar 16
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Annuncio • Mar 13
Soulbrain Holdings Co., Ltd., Annual General Meeting, Mar 26, 2026 Soulbrain Holdings Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: auditorium, 52, geumto-ro, sujeong-gu, gyeonggi-do, seongnam South Korea Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩43,900, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 55% over the past three years. New Risk • Feb 14
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.0% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Declared Dividend • Feb 13
Dividend increased to ₩500 Dividend of ₩500 is 127% higher than last year. Ex-date: 30th March 2026 Payment date: 1st January 1970 Dividend yield will be 1.0%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 5%. Cash payout ratio: 8%. Annuncio • Feb 12
Soulbrain Holdings Co., Ltd. announces Annual dividend Soulbrain Holdings Co., Ltd. announced Annual dividend of KRW 500.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 40% After last week's 40% share price gain to ₩55,900, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 120% over the past three years. New Risk • Jan 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩42,850, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 66% over the past three years. Annuncio • Sep 03
Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) acquired AIBIT Co., Ltd. Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) acquired AIBIT Co., Ltd. on September 1, 2025.
Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) completed the acquisition of AIBIT Co., Ltd. on September 1, 2025. New Risk • Aug 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (9.0% net profit margin). Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩45,950, the stock trades at a trailing P/E ratio of 19.5x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 128% over the past three years. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩41,150, the stock trades at a trailing P/E ratio of 17.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 115% over the past three years. New Risk • Jun 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (9.0% net profit margin). Valuation Update With 7 Day Price Move • Jun 04
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₩35,950, the stock trades at a trailing P/E ratio of 15.5x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 44% over the past three years. New Risk • May 29
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.0% Last year net profit margin: 14% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company. Annuncio • Apr 17
Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces an Equity Buyback for KRW 10,000 million worth of its shares. Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares pursuant to a contract with NH INVESTMENT & SECURITIES CO.,LTD. The purpose of the program is to stabilize stock prices and enhance shareholder value. The program will expire on October 14, 2025. As of April 14, 2025, the company had 564,961 and 0 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩30,250, the stock trades at a trailing P/E ratio of 10.5x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 8.5% over the past three years. Upcoming Dividend • Mar 21
Upcoming dividend of ₩220 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 21 April 2025. Payout ratio is a comfortable 5.2% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (1.7%). Annuncio • Mar 12
Soulbrain Holdings Co., Ltd., Annual General Meeting, Mar 26, 2025 Soulbrain Holdings Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 20, pangyo-ro 289beon-gil, bundang-gu, gyeonggi-do, seongnam South Korea Valuation Update With 7 Day Price Move • Mar 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩31,500, the stock trades at a trailing P/E ratio of 8.2x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 15% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩200 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 5.2% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. This is currently the only risk that has been identified for the company. Annuncio • Dec 05
Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces an Equity Buyback for KRW 10,000 million worth of its shares. Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares pursuant to a contract with NH Investment & Securities Co., Ltd. The purpose of the program is to stabilize stock prices and enhance shareholder value. The program will expire on June 04, 2025. As of December 4, 2024, the company had 302,463 and 0 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩43,200, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 5.5% over the past three years. Valuation Update With 7 Day Price Move • Sep 06
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩46,700, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩44,350, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 21% over the past three years. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩57,200, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 49% over the past three years. Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩79,000, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩73,700, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 103% over the past three years. Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩69,900, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 86% over the past three years. Buy Or Sell Opportunity • May 22
Now 22% overvalued Over the last 90 days, the stock has fallen 11% to ₩66,700. The fair value is estimated to be ₩54,560, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last 3 years. Earnings per share has grown by 12%. Valuation Update With 7 Day Price Move • May 17
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩85,200, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years. Buy Or Sell Opportunity • May 03
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 47% to ₩67,400. The fair value is estimated to be ₩54,867, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last 3 years. Earnings per share has grown by 12%. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩61,000, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 50% over the past three years. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩53,000, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Reported Earnings • Mar 22
Full year 2023 earnings released: EPS: ₩4,406 (vs ₩3,107 in FY 2022) Full year 2023 results: EPS: ₩4,406 (up from ₩3,107 in FY 2022). Revenue: ₩661.6b (up 17% from FY 2022). Net income: ₩91.0b (up 42% from FY 2022). Profit margin: 14% (up from 11% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 11% per year. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₩65,600, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 44% over the past three years. New Risk • Feb 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩45,950, the stock trades at a trailing P/E ratio of 11x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 2.7% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩170 per share at 0.4% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Valuation Update With 7 Day Price Move • Dec 04
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩42,300, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 1.2% over the past three years. Valuation Update With 7 Day Price Move • Nov 15
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩39,450, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 8.2% over the past three years. New Risk • Oct 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩33,300, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 24% over the past three years. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩33,050, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 31% over the past three years. New Risk • Aug 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.9% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change). Valuation Update With 7 Day Price Move • Aug 16
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ₩32,500, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 33% over the past three years. Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩34,000, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 320% over the past three years. Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩28,150, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 201% over the past three years. Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 4.4% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Byungchang Kang was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 20
Investor sentiment improved over the past week After last week's 16% share price gain to ₩23,900, the stock trades at a trailing P/E ratio of 8.7x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 186% over the past three years. Annuncio • Sep 30
Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces an Equity Buyback for KRW 5,000 million worth of its shares. Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) announces a share repurchase program. Under the program, the company will repurchase up to $5,000 million worth of its shares according to the contract with Mirae Asset Securities Co., Ltd. The purpose of the program is stock price stability and shareholder value enhancement. The program will expire on March 29, 2023. As of September 28, 2022, the company had 0 and 12,430 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively. Valuation Update With 7 Day Price Move • Aug 17
Investor sentiment improved over the past week After last week's 18% share price gain to ₩25,400, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 227% over the past three years. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩21,400, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 331% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Byungchang Kang was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Price Target Changed • Feb 13
Price target decreased to ₩110,000 Down from ₩198,947, the current price target is provided by 1 analyst. New target price is 279% above last closing price of ₩29,050. Stock is down 37% over the past year. The company is forecast to post earnings per share of ₩19,730 for next year compared to ₩4,028 last year. Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩38,600, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 600% over the past three years. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improved over the past week After last week's 25% share price gain to ₩42,500, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 650% over the past three years. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improved over the past week After last week's 16% share price gain to ₩40,850, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 570% over the past three years. Is New 90 Day High Low • Jan 25
New 90-day high: ₩48,050 The company is up 12% from its price of ₩42,850 on 27 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 40% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩150,175 per share. Is New 90 Day High Low • Jan 04
New 90-day high: ₩46,450 The company is up 2.0% from its price of ₩45,650 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩150,135 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩850 Per Share Will be paid on the 20th of April to those who are registered shareholders by the 29th of December. The trailing yield of 3.7% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%). Price Target Changed • Dec 18
Price target raised to ₩183,907 Up from ₩171,818, the current price target is an average from 6 analysts. The new target price is 329% above the current share price of ₩42,900. Is New 90 Day High Low • Dec 08
New 90-day low: ₩41,850 The company is down 12% from its price of ₩47,700 on 09 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩266,773 per share. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS ₩462 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: ₩56.7b (down 11% from 3Q 2019). Net income: ₩4.31b (up ₩6.87b from 3Q 2019). Profit margin: 7.6% (up from net loss in 3Q 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Sep 24
New 90-day low: ₩44,550 The company is down 74% from its price of ₩170,371 on 25 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩264,515 per share. Annuncio • Aug 06
The Board of Soulbrain Co.,Ltd. (KOSDAQ:A036830) completed the spin-off of Manufacturing division of Soulbrain Co.,Ltd. The Board of Soulbrain Co.,Ltd. (KOSDAQ:A036830) announced the spin-off of Manufacturing division of Soulbrain Co.,Ltd. on January 22, 2020. Shareholders of Soulbrain shall be divided by the method of personnel division in which shares of a newly split new company are allocated in proportion to the shareholding ratio at the date of the new share allocation. The spin-off ratio for assignment of shares is 0.4470885. However, among the businesses operated by the divided companies, the manufacturing division ("divided target business division") is divided to establish a new split-division company, and the divided companies remain in the investment business division. Fractional shares of less than 1 share shall be paid in cash at the closing price of the relisting date of the new shares of a new spin off Soulbrain Co.,Ltd. After the split, the newly issued shares of the newly split company will be re-listed on the KOSDAQ market after the re-listing under the KOSDAQ listing rules of the Korea Exchange. Post spin off completion, the surviving Company name will be Soulbrain Holdings Co.,Ltd. (tentative name). As at September 30, 2019, the business reported total assets of KRW 502.6 billion and total capital of KRW 358.3 billion. New stock allocation date is June 30, 2020 and scheduled listing of new shares date is August 6, 2020. Scheduled date of shareholders' meeting is May 14, 2020. Expected period of suspension of trading is from June 29, 2020 to August 5, 2020. The day of spin off shall be July 1, 2020.
The Board of Soulbrain Co.,Ltd. (KOSDAQ:A036830) completed the spin-off of Manufacturing division of Soulbrain Co.,Ltd. on July 1, 2020. Soulbrain divided the company into a holding company and a business company, as announced earlier. Soulbrain Holdings will be the surviving corporation and Soulbrain the spin-off that will continue its previous businesses.